Role of FGFs in the control of programmed cell death during limb development.
We have investigated the role of FGFs in the control of programmed cell death during limb development by analyzing the effects of increasing and blocking FGF signaling in the avian limb bud. BMPs are currently considered as the signals responsible for cell death. Here we show that FGF signaling is also necessary for apoptosis and that the establishment of the areas of cell death is regulated by the convergence of FGF- and BMP-mediated signaling pathways. As previously demonstrated, cell death is inhibited for short intervals (12 hours) after administration of FGFs. However, this initial inhibition is followed (24 hours) by a dramatic increase in cell death, which can be abolished by treatments with a BMP antagonist (Noggin or Gremlin). Conversely, blockage of FGF signaling by applying a specific FGF-inhibitor (SU5402) into the interdigital regions inhibits both physiological cell death and that mediated by exogenous BMPs. Furthermore, FGF receptors 1, 2 and 3 are expressed in the autopodial mesoderm during the regression of the interdigital tissue, and the expression of FGFR3 in the interdigital regions is regulated by FGFs and BMPs in the same fashion as apopotosis. Together our findings indicate that, in the absence of FGF signaling BMPs are not sufficient to trigger apoptosis in the developing limb. Although we provide evidence for a positive influence of FGFs on BMP gene expression, the physiological implication of FGFs in apoptosis appears to result from their requirement for the expression of genes of the apoptotic cascade. We have identified MSX2 and Snail as candidate genes associated with apoptosis the expression of which requires the combined action of FGFs and BMPs.
Montero
J A
JA
Departamento de Ciencias Morfológicas y Biología Celular y Animal, Universidad de Extremadura, Badajoz 06071, Spain.
Gañan
Y
Y
Macias
D
D
Rodriguez-Leon
J
J
Sanz-Ezquerro
J J
JJ
Merino
R
R
Chimal-Monroy
J
J
Nieto
M A
MA
Hurle
J M
JM
D000818:Animals; D017209:Apoptosis; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D002642:Chick Embryo; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D004372:Ducks / Q000196:embryology; D005346:Fibroblast Growth Factors / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D005786:Gene Expression Regulation; D018398:Homeodomain Proteins; D006801:Humans; D018878:Limb Buds / Q000196:embryology*; D015398:Signal Transduction; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors / Q000235:genetics
D019485:Bone Morphogenetic Proteins; D004268:DNA-Binding Proteins; D018398:Homeodomain Proteins; C084119:MSX2 protein; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors; D005346:Fibroblast Growth Factors